GlassScriptPhysician profile
Yat Min Chen
NPI 1316919871
$2,322.29
in general payments reported to CMS, 2019-2025
19 companies · $986 in 2025
The $986 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $67.82 · 2021: $562 · 2022: $138 · 2023: $307 · 2024: $44.08 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978 · Travel and Lodging: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.89 |
| Travel and Lodging | $359.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $838.57 | 2025 | |
| Hologic Sales and Service, LLC | $201.39 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $180.15 | 2019-2022 | |
| Mission Pharmacal Company | $171.98 | 2019-2024 | Ferralet 90, Citranatal, Uribel Tabs |
| Sumitomo Pharma America, INC. | $148.26 | 2023 | Myfembree |
| Coopersurgical, INC. | $139.52 | 2021 | |
| Gilead Sciences, INC. | $136.24 | 2021-2022 | |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $118.14 | 2021 | |
| Pfizer INC. | $37.45 | 2019-2021 | |
| Exeltis, USA INC. | $34.72 | 2019-2022 | |
| Roche Diagnostics Corporation | $32.17 | 2019 | |
| Lupin INC. | $32.13 | 2019-2020 | |
| Ethicon US, LLC | $32.09 | 2024 | Vistaseal |
| Agile Therapeutics, INC. | $29.64 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $19.39 | 2023 | Balcoltra |
| Therapeuticsmd, INC. | $16.88 | 2021 | |
| Allergan, INC. | $16.81 | 2019 | |
| Virtus Pharmaceuticals LLC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yat Min Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.